Skip to content
Stop using now Drug recall · FDA · Published September 20, 2023

KVK Tech Betaxolol Tablets Recall: Risk of Oxycodone Contamination

KVK Tech recalls 100-count Betaxolol 10mg tablets (Rx only) due to potential oxycodone contamination. Affected lots may contain dangerous opioid tablets.

🇺🇸 FDA recall #D-0049-2024DrugKVK Tech ›
Take action

Contact the company

Recalling firmKVK-Tech, Inc.110 Terry Dr · Newtown, PA 18940-3427
✎ GovInfoNow plain-language explainer

KVK Tech is recalling 100-count Betaxolol 10mg tablets (Rx only) because some bottles might contain oxycodone HCl tablets. This is dangerous as oxycodone is a potent opioid that could cause overdose if taken by mistake. Read more at govinfonow.com/recall/33129-kvk-tech-betaxolol-tablets-recall-risk-of-oxycodone-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/33129-kvk-tech-betaxolol-tablets-recall-risk-of-oxycodone-contamination · Updated August 17, 2026 · FDA enforcement record: FDA #D-0049-2024

Cite this page

“KVK Tech Betaxolol Tablets Recall: Risk of Oxycodone Contamination.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33129-kvk-tech-betaxolol-tablets-recall-risk-of-oxycodone-contamination. Based on FDA recall #D-0049-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0049-2024%22&limit=1).

The FDA announced on Sept. 20, 2023, that KVK Tech, Inc. voluntarily recalled Betaxolol Tablets, USP 10 mg due to the potential presence of oxycodone HCl tablets in the bottles. The recall affects 1,488 bottles distributed nationwide.

How to tell if you have it

  • Brand: KVK Tech
  • Product: Betaxolol Tablets, USP 10 mg, Rx Only, 100 count bottles
  • Manufacturer: KVK Tech Inc., Newtown, PA 18940
  • NDC#: 10702-013-01
  • Lot #: 17853A
  • Expiration Date: 06/30/2027

The hazard

The recall is due to the potential presence of oxycodone HCl tablets, USP 5 mg in bottles of Betaxolol Tablets, USP 10 mg. The FDA classified this as a Class I recall.

Context

GovInfoNow's records show KVK Tech, Inc. has 11 other recalls on record since Dec. 11, 2013. Other recent recalls of similar products include SpecGx Oxycodone/Acetaminophen Tablets Recall (Dec. 16, 2025), Oxycodone 5mg Tablets Recall (Jan. 14, 2026), and Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall (Jan. 21, 2026).

How to tell if you have this one

Check for the lot number 17853A on the bottle label. The product is a 100-count Betaxolol 10mg tablet bottle made in the USA by KVK Tech in Newtown, PA. The expiration date is June 30, 2027.

  • Brand
    KVK Tech
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled Betaxolol tablets if you have them. Do not take any tablets from this lot.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide in the USA and PR” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 22 months after the firm started it.

1. Firm started the recall: Sep 20, 202312. FDA classified it Class I: Oct 18, 202323. Published in FDA’s Enforcement Report: Oct 25, 202334. FDA terminated the recall: Jul 29, 2025420232025
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0049-2024 (September 20, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0049-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA